Thomas Arnoux
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Co-authors
- Rebecca M. Pruss (4 shared papers)Thierry Bordet (3 shared papers)Magali Michaud (3 shared papers)Caroline Gouarné (2 shared papers)Virginie Gourdou‐Latyszenok (2 shared papers)Cédric Raoul (1 shared paper)Brigitte Pettmann (1 shared paper)Julianne Aebischer (1 shared paper)
In The Last Decade
Thomas Arnoux
7 papers receiving 1.2k citations
Thomas Arnoux's Hit Papers
Peers
Comparison fields: 5 of 56
- Immunology 591
- Oncology 352
- Genetics 87
- Otorhinolaryngology 31
- Neurology 43
Countries citing papers authored by Thomas Arnoux
This map shows the geographic impact of Thomas Arnoux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Arnoux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Arnoux more than expected).
Fields of papers citing papers by Thomas Arnoux
This network shows the impact of papers produced by Thomas Arnoux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Arnoux. The network helps show where Thomas Arnoux may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Arnoux, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells Hit paper breakdown → | 2018 | 996 |
| 2 | 2012 | 81 | |
| 3 | 2010 | 60 | |
| 4 | 2015 | 28 | |
| 5 | 2016 | 17 | |
| 6 | 2015 | 6 | |
| 7 | 2012 | 4 |
About Thomas Arnoux
Thomas Arnoux is a scholar working on Oncology, Genetics, Pharmacology, Neurology and Pathology and Forensic Medicine, having authored 7 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (1 paper), Amyotrophic Lateral Sclerosis Research (1 paper), Neurogenetic and Muscular Disorders Research (1 paper), Cardiac Ischemia and Reperfusion (1 paper), Cell death mechanisms and regulation (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Immunology (591 citations), Oncology (352 citations), Genetics (87 citations), Otorhinolaryngology (31 citations) and Neurology (43 citations). Thomas Arnoux has collaborated with scholars based in France, Germany and Sweden. Frequent co-authors include Rebecca M. Pruss, Thierry Bordet, Magali Michaud, Caroline Gouarné, Virginie Gourdou‐Latyszenok, Cédric Raoul, Brigitte Pettmann, Julianne Aebischer, Nathalie Bernard‐Marissal and Claire Sunyach. Their work appears in journals such as Pharmacology Research & Perspectives, Journal for ImmunoTherapy of Cancer, Neuropharmacology, European Journal of Pharmacology and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.